Insulin resistance of denervated rat muscle: a model for impaired receptor-function coupling.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMID 6437249)

Published in Am J Physiol on November 01, 1984

Authors

C F Burant, S K Lemmon, M K Treutelaar, M G Buse

Articles by these authors

Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science (1993) 3.52

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1998) 3.41

Molecular biology of mammalian glucose transporters. Diabetes Care (1990) 3.33

Leucine. A possible regulator of protein turnover in muscle. J Clin Invest (1975) 2.67

The yeast adaptor protein complex, AP-3, is essential for the efficient delivery of alkaline phosphatase by the alternate pathway to the vacuole. J Cell Biol (1997) 2.32

Structure and function of mammalian facilitative sugar transporters. J Biol Chem (1993) 2.14

Suppressors of YCK-encoded yeast casein kinase 1 deficiency define the four subunits of a novel clathrin AP-like complex. EMBO J (1997) 2.10

Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). J Biol Chem (1990) 2.08

Protease B of the lysosomelike vacuole of the yeast Saccharomyces cerevisiae is homologous to the subtilisin family of serine proteases. Mol Cell Biol (1987) 1.99

Bms1p, a novel GTP-binding protein, and the related Tsr1p are required for distinct steps of 40S ribosome biogenesis in yeast. RNA (2001) 1.98

Clathrin functions in the absence of heterotetrameric adaptors and AP180-related proteins in yeast. EMBO J (1999) 1.79

A late Golgi sorting function for Saccharomyces cerevisiae Apm1p, but not for Apm2p, a second yeast clathrin AP medium chain-related protein. Mol Biol Cell (1995) 1.77

Genetic dissection of sperm individualization in Drosophila melanogaster. Development (1998) 1.72

Cloning, tissue expression, and chromosomal localization of SUR2, the putative drug-binding subunit of cardiac, skeletal muscle, and vascular KATP channels. Diabetes (1996) 1.65

Bovine fibroblast growth factor: comparison of brain and pituitary preparations. J Cell Biol (1982) 1.61

Oxidation of branched chain amino acids by isolated hearts and diaphragms of the rat. The effect of fatty acids, glucose, and pyruvate respiration. J Biol Chem (1972) 1.61

Glucose transporter isoforms GLUT1 and GLUT3 transport dehydroascorbic acid. J Biol Chem (1997) 1.60

Human intestinal glucose transporter expression and localization of GLUT5. Am J Physiol (1992) 1.60

Glucose transporter expression in brain. cDNA sequence of mouse GLUT3, the brain facilitative glucose transporter isoform, and identification of sites of expression by in situ hybridization. J Biol Chem (1992) 1.50

Purification and characterization of branched chain alpha-ketoacid dehydrogenase from bovine liver mitochondria. J Biol Chem (1979) 1.42

Prevention of hyperglycemia in the Zucker diabetic fatty rat by treatment with metformin or troglitazone. Am J Physiol (1996) 1.41

Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle. Proc Natl Acad Sci U S A (2001) 1.38

Sequence, tissue distribution, and functional characterization of the rat fructose transporter GLUT5. Am J Physiol (1993) 1.38

Suppressors of clathrin deficiency: overexpression of ubiquitin rescues lethal strains of clathrin-deficient Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.36

Brain fibroblast growth factor: nonidentity with myelin basic protein fragments. J Biol Chem (1980) 1.34

Effects of diabetes and hyperglycemia on the hexosamine synthesis pathway in rat muscle and liver. Diabetes (1995) 1.29

High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes (2000) 1.27

Calpains play a role in insulin secretion and action. Diabetes (2001) 1.25

Substrate specificity and stabilization by thiamine pyrophosphate of rat liver branched chain alpha-ketoacid dehydrogenase. Biochem Med (1978) 1.24

Complementation of apolipoprotein B mRNA editing by human liver accompanied by secretion of apolipoprotein B48. J Biol Chem (1994) 1.23

Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J Biol Chem (2001) 1.22

The effect of epinephrine, glucagon, and the nutritional state on the oxidation of branched chain amino acids and pyruvate by isolated hearts and diaphragms of the rat. J Biol Chem (1973) 1.21

The Drosophila clathrin heavy chain gene: clathrin function is essential in a multicellular organism. Genetics (1993) 1.19

SCD5, a suppressor of clathrin deficiency, encodes a novel protein with a late secretory function in yeast. Mol Biol Cell (1996) 1.16

Alternative splicing of sur2 Exon 17 regulates nucleotide sensitivity of the ATP-sensitive potassium channel. J Biol Chem (1999) 1.15

Pre-exposure to glucosamine induces insulin resistance of glucose transport and glycogen synthesis in isolated rat skeletal muscles. Study of mechanisms in muscle and in rat-1 fibroblasts overexpressing the human insulin receptor. Diabetes (1993) 1.15

Effects of branched-chain amino acids on protein turnover. Diabetes Metab Rev (1989) 1.10

Purification and partial characterization of bovine pituitary fibroblast growth factor. J Cell Biochem (1983) 1.09

Diabetes-induced functional and structural changes in insulin receptors from rat skeletal muscle. J Clin Invest (1986) 1.09

Diabetes-related changes in cAMP response element-binding protein content enhance smooth muscle cell proliferation and migration. J Biol Chem (2001) 1.08

Hexose transporter expression in rat small intestine: effect of diet on diurnal variations. Am J Physiol (1996) 1.07

Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes (1999) 1.06

Antibody to type I insulinlike growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am J Pathol (1989) 1.04

Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.03

Regulation of branched-chain amino acid oxidation in isolated muscles, nerves and aortas of rats. Biochem J (1975) 1.03

In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate. Pediatr Res (1978) 1.02

Intestinal fructose absorption: clinical and molecular aspects. J Pediatr Gastroenterol Nutr (1999) 1.02

Effect of denervation on the expression of two glucose transporter isoforms in rat hindlimb muscle. J Clin Invest (1991) 1.01

Effect of free fatty acids and insulin on protein synthesis and amino acid metabolism of isolated rat diaphragms. Diabetes (1967) 1.00

The effect of L-dopa on plasma growth hormone, insulin, and thyroxine. J Clin Endocrinol Metab (1972) 1.00

Novel functions of clathrin light chains: clathrin heavy chain trimerization is defective in light chain-deficient yeast. J Cell Sci (1997) 0.98

Lower calorie intake enhances muscle insulin action and reduces hexosamine levels. Am J Physiol Regul Integr Comp Physiol (2000) 0.98

Detection of type 1 insulinlike growth factor (IGF) receptors in Wilms' tumors. Am J Pathol (1988) 0.97

Effects of glucose, pyruvate, lactate, and amino acids on muscle protein synthesis. Am J Physiol (1982) 0.96

Human recombinant alpha 2-HS glycoprotein is produced in insect cells as a full length inhibitor of the insulin receptor tyrosine kinase. Horm Metab Res (1998) 0.95

Effect of alpha-adrenergic blockade on insulin secretion in man. Metabolism (1970) 0.95

Glucocorticoids regulate Na+/H+ exchange expression and activity in region- and tissue-specific manner. Am J Physiol (1994) 0.95

The inhibition of islet superoxide dismutase by diabetogenic drugs. Diabetes (1981) 0.95

Leucine and isoleucine activate skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo. Am J Physiol (1986) 0.94

Synthesis of hemoglobin Aic and related minor hemoglobin by erythrocytes. In vitro study of regulation. J Clin Invest (1979) 0.94

Activation of rat liver branched-chain 2-oxo acid dehydrogenase in vivo by glucagon and adrenaline. Biochem J (1985) 0.93

The effect of diabetes, insulin, and the redox potential on leucine metabolism by isolated rat hemidiaphragm. Endocrinology (1976) 0.93

Superoxide dismutase in human islets of Langerhans. N Engl J Med (1981) 0.93

Effects of hypercortisolemia and diabetes on skeletal muscle insulin receptor function in vitro and in vivo. Am J Physiol (1989) 0.93

Stabilization of mammalian liver branched-chain alpha-ketoacid dehydrogenase by thiamin pyrophosphate. Arch Biochem Biophys (1980) 0.91

The effect of denervation and insulin on protein synthesis in the isolated rat diaphragm. Metabolism (1965) 0.90

Administration of endotoxin, tumor necrosis factor, or interleukin 1 to rats activates skeletal muscle branched-chain alpha-keto acid dehydrogenase. J Clin Invest (1990) 0.90

Scintigraphic diagnosis of peritoneo-pleural communication in the absence of ascites. Clin Nucl Med (1994) 0.90

In vivo effects of branched chain amino acids on muscle protein synthesis in fasted rats. Horm Metab Res (1981) 0.90

Effects of diabetes on oxidative decarboxylation of branched-chain keto acids. Am J Physiol (1980) 0.89

The small intestinal fructose transporters: site of dietary perception and evidence for diurnal and fructose sensitive control elements. Biochim Biophys Acta (1998) 0.89

Phosphorylation of insulin receptors solubilized from rat skeletal muscle. Diabetes (1984) 0.89

Branched-chain amino acid metabolism in rat muscle: abnormal regulation in acidosis. Am J Physiol (1987) 0.88

Effects of diabetes and starvation on skeletal muscle branched-chain alpha-keto acid dehydrogenase activity. Am J Physiol (1988) 0.88

Regulation of rat liver branched-chain alpha-keto acid dehydrogenase activity by meal frequency and dietary protein. J Nutr (1990) 0.87

Comparison of insulin and insulin-like growth factor I receptors from rat skeletal muscle and L-6 myocytes. Biochem Biophys Res Commun (1987) 0.87

Protective role of superoxide dismutase against diabetogenic drugs. J Clin Invest (1982) 0.86

Glucocorticoid-mediated activation of muscle branched-chain alpha-keto acid dehydrogenase in vivo. Am J Physiol (1987) 0.86

In vitro and in vivo activation of the insulin receptor kinase in control and denervated skeletal muscle. J Biol Chem (1986) 0.86

Catabolism of branched-chain amino acids by diaphragm muscles of fasted and diabetic rats. Metabolism (1985) 0.86

Studies concerning the specificity of the effect of leucine on the turnover of proteins in muscles of control and diabetic rats. Biochim Biophys Acta (1977) 0.86

The effect of diabetes and the redox potential on amino acid content and release by isolated rat hemidiaphragms. Metabolism (1980) 0.85

In vitro effect of branched chain amino acids on the ribosomal cycle in muscles of fasted rats. Horm Metab Res (1979) 0.85

Effects of troglitazone on substrate storage and utilization in insulin-resistant rats. Am J Physiol (1999) 0.85

General stimulation of muscle protein synthesis by branched chain amino acids in vitro. Proc Soc Exp Biol Med (1979) 0.85

Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms. Endocrinology (1991) 0.84

Effect of streptozotocin on erythrocyte and retinal superoxide dismutase. Diabetologia (1978) 0.84

Human insulin receptor radioimmunoassay: applicability to insulin-resistant states. Am J Physiol (1989) 0.84

Sequential activation of two mitogen activated protein (MAP) kinase isoforms in rat skeletal muscle following insulin injection. Biochem Biophys Res Commun (1993) 0.83

Modulation of rat skeletal muscle branched-chain alpha-keto acid dehydrogenase in vivo. Effects of dietary protein and meal consumption. J Clin Invest (1987) 0.83

Radionuclide bone imaging of femoral prostheses with porous coatings. Clin Orthop Relat Res (1981) 0.83